February 3, 2025
An investigative lung MRI that uses inhaled perfluoropropane gas has demonstrated an ability to identify damaged regions of the lung in patients with asthma and chronic […]
January 31, 2025
The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to prevent invasive disease and pneumonia […]
January 30, 2025
(Reuters) – Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on strong efficacy shown […]
January 30, 2025
TOPLINE: Emergency and hospital medicine physicians often chose anticoagulants for acute pulmonary embolism (PE) based on institutional culture and past practices rather than clinical guidelines. Common […]
January 28, 2025
In 2016, Brady Scott was in his parents’ home in Garrett, Kentucky, scrolling his Facebook feed when a post from a local newspaper caught his attention. […]
January 28, 2025
TOPLINE: Nicotinamide riboside (NR) supplementation may reduce airway inflammation and, thereby, lower the risk for exacerbation in patients with noneosinophilic chronic obstructive pulmonary disease (COPD) who […]
January 23, 2025
TOPLINE: An increased muscle-to-fat (MF) ratio is associated with improved lung function in men and nonsmoking women of middle age. Increases in the MF ratio are […]
January 22, 2025
TOPLINE: Vanzacaftor-tezacaftor-deutivacaftor, a novel therapeutic, once-daily drug, demonstrates noninferiority to elexacaftor-tezacaftor-ivacaftor (the twice-daily, standard-of-care drug) in lung function improvement with an acceptable safety profile in patients […]
January 21, 2025
A simple, noninvasive nasal swab identified a predominance of T2-low asthma subtypes in racial and ethnic minority pediatric patients, based on data from three independent studies […]